Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Academic Article uri icon

Overview

abstract

  • Obesity increases the risk of developing several cancers including oesophageal adenocarcinoma (OAC). Obesity is characterised by hyperleptinaemia and hypoadiponectinaemia: we have hypothesised that these hormonal factors may contribute to the progression of OAC. We have examined the effects of leptin and adiponectin on proliferation of OAC cells. Leptin-stimulated proliferation in four different OAC lines (OE33, OE19, BIC-1 and FLO) and this was inhibited by globular but not full length adiponectin. All four OAC lines expressed both adiponectin-receptor isoforms (AdipoR1 and AdipoR2). Globular adiponectin also inhibited leptin-induced proliferation in rat IEC-18 cells which only expressed AdipoR1. Specific inhibitors of 5'-AMP-activated protein kinase (Compound C) and serine/threonine phosphatases (okadaic acid) and a specific siRNA to AdipoR1 blocked the anti-proliferative effects of adiponectin. Adiponectin inhibited leptin-induced Akt phosphorylation; this action was sensitive to okadaic acid but not to Compound C. Adiponectin deficiency may contribute to the promotion of OAC in obesity.

publication date

  • February 7, 2008

Research

keywords

  • Adenocarcinoma
  • Adiponectin
  • Cell Proliferation
  • Esophageal Neoplasms
  • Leptin
  • Obesity
  • Receptors, Adiponectin

Identity

Scopus Document Identifier

  • 39849087832

Digital Object Identifier (DOI)

  • 10.1016/j.mce.2008.01.023

PubMed ID

  • 18313838

Additional Document Info

volume

  • 285

issue

  • 1-2